Daunoxome (DNX, Nexstar) was given, as a single agent, to 11 patients with very poor-risk acute leukemia. Pharmacokinetic data were also obtained from 9 of the 11 cases. This small pilot study show that the toxic profile of this liposomal-encapsulated anthracycline is low.
Liposome encapsulated daunorubicin (daunoxome) for acute leukemia
Pea, F;Visani, G;
2000
Abstract
Daunoxome (DNX, Nexstar) was given, as a single agent, to 11 patients with very poor-risk acute leukemia. Pharmacokinetic data were also obtained from 9 of the 11 cases. This small pilot study show that the toxic profile of this liposomal-encapsulated anthracycline is low.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
